MAZE
Maze Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$50.21
-1.62 ▼ -3.13%
🌙 3월 13일 4:38 PM ET (한국 3/14 05:38)
$50.21
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -2.25 | Insider Own | 44.8% | Shs Outstand | 0.05B | Perf Week | 12% |
| Market Cap | 2.42B | Forward P/E | - | EPS next Y | 0.06% | Insider Trans | -1.28% | Shs Float | 0.03B | Perf Month | 6.33% |
| Enterprise Value | 2.06B | PEG | - | EPS next Q | -0.71 | Inst Own | 57.95% | Short Float | 12.95% | Perf Quarter | 30.04% |
| Income | -0.10B | P/S | - | EPS this Y | -348.66% | Inst Trans | 9.98% | Short Ratio | 7.29 | Perf Half Y | 102.46% |
| Sales | 0.00B | P/B | 6.36 | EPS next 5Y | - | ROA | -28.15% | Short Interest | 3.44M | Perf YTD | 21.19% |
| Book/sh | 7.89 | P/C | 6.29 | EPS past 3/5Y | - | ROE | -36.13% | 52W High | -4.48% ($52.56) | Perf Year | 344.34% |
| Cash/sh | 7.98 | P/FCF | - | Sales past 3/5Y | - | ROIC | -25.44% | 52W Low | 648.29% ($6.71) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 9.35% 6.41% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.19 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 17.7 | EPS Q/Q | -1029.6% | Profit Margin | - | RSI (14) | 59.95 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 17.7 | Sales Q/Q | -100% | SMA20 | 7.77% ($46.59) | Beta | 3.86 | Target Price | $57.4 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 11000000 | SMA50 | 12.31% ($44.71) | Rel Volume | 2.26 | Prev Close | $51.83 |
| Employees | 125 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 6.81% - | SMA200 | 74.44% ($28.78) | Avg Volume(3M) | 0.47M | Price | $50.21 |
| IPO | 2025/1/31 | Option/Short | Yes/Yes | Trades | 10422 | Volume | 1,065,922 | Change | -3.13% |
뉴스 로딩 중...